pHion Therapeutics Limited

pHion Therapeutics is a therapeutic vaccine development company, spun out of Queen's University Belfast (N.Ireland), School of Pharmacy. pHion is utilising its patented peptide based drug delivery system (DDS) termed RALA that, when combined with mRNA, generates a uniquely potent therapeutic CD8+ response, without provoking an innate immune response. RALA is a peptide based DDS which condenses anionic cargo of any size (DNA, RNA, small molecules) to nanoparticles, and is highly efficient at cellular entry, without the manufacturing complexity or safety issues of viruses. pHion's therapeutic vaccine development is initially focused on viral infections as it evokes a strong interferon gamma response. We believe that the RALA/mRNA technology marks the advent of a new generation of therapeutic vaccines that could clear infectious diseases on a global scale.